CATANIA, MARIA VINCENZA
 Distribuzione geografica
Continente #
AS - Asia 2.620
NA - Nord America 1.208
EU - Europa 540
SA - Sud America 394
AF - Africa 35
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.804
Nazione #
US - Stati Uniti d'America 1.161
SG - Singapore 1.029
CN - Cina 704
BR - Brasile 327
HK - Hong Kong 263
VN - Vietnam 241
IT - Italia 190
FR - Francia 150
KR - Corea 110
JP - Giappone 88
NL - Olanda 59
IN - India 43
BD - Bangladesh 38
GB - Regno Unito 30
DE - Germania 28
AR - Argentina 26
CA - Canada 20
ID - Indonesia 17
IL - Israele 17
MX - Messico 17
FI - Finlandia 14
EC - Ecuador 13
RU - Federazione Russa 13
SA - Arabia Saudita 10
ES - Italia 8
TR - Turchia 8
UZ - Uzbekistan 8
CL - Cile 7
IQ - Iraq 7
PY - Paraguay 7
SE - Svezia 7
DZ - Algeria 6
PH - Filippine 6
PK - Pakistan 6
PL - Polonia 6
ZA - Sudafrica 6
CO - Colombia 5
MA - Marocco 5
AU - Australia 4
EG - Egitto 4
IE - Irlanda 4
PE - Perù 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CZ - Repubblica Ceca 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
LV - Lettonia 3
UA - Ucraina 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BJ - Benin 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
GG - Guernsey 1
GT - Guatemala 1
KW - Kuwait 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.804
Città #
Singapore 619
Santa Clara 550
Hefei 259
Hong Kong 257
Beijing 117
San Jose 117
Lauterbourg 113
Seoul 103
Ho Chi Minh City 95
Ashburn 73
Tokyo 71
Dallas 51
Hanoi 50
Los Angeles 47
São Paulo 34
Rome 23
Buffalo 19
Milan 19
New York 19
Bengaluru 16
Palermo 16
Minamishinagawa 15
Rio de Janeiro 15
Orem 14
Frankfurt am Main 12
Catania 11
Messina 11
Dhaka 10
Helsinki 10
Curitiba 9
Naples 9
Belo Horizonte 8
Brasília 8
Da Nang 8
Tashkent 8
Council Bluffs 7
Guarulhos 7
Manchester 7
Montreal 7
Quận Bình Thạnh 7
Salvador 7
Brooklyn 6
Guangzhou 6
Haiphong 6
Porto Alegre 6
Riyadh 6
Can Tho 5
Paris 5
Quito 5
Shanghai 5
Baghdad 4
Bangkok 4
Biên Hòa 4
Bình Dương Province 4
Chennai 4
Chicago 4
Guayaquil 4
Ha Long 4
Hoàng Mai 4
Hòa Bình 4
Lappeenranta 4
London 4
Mexico City 4
Mumbai 4
Osasco 4
Phoenix 4
Sorocaba 4
Stockholm 4
Thái Nguyên 4
Toronto 4
Vũng Tàu 4
Warsaw 4
Amman 3
Asunción 3
Bexley 3
Bến Tre 3
Casablanca 3
Dublin 3
Dundee 3
Jakarta 3
Johannesburg 3
Juiz de Fora 3
Lima 3
Madrid 3
Manaus 3
Melbourne 3
New Delhi 3
Newark 3
Nuremberg 3
Panama City 3
Philadelphia 3
Potenza 3
Quận Bảy 3
Riga 3
Shenzhen 3
São Luís 3
The Bronx 3
Tianjin 3
Verona 3
Volta Redonda 3
Totale 3.080
Nome #
Endotelina-1: un nuovo target farmacologico per la Sclerosi Laterale Amiotrofica? 102
Activation of 5-HT7 receptors for serotonin rescues hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome through a cyclic AMP-mediated mechanism involving Cyclin-dependent Kinase 5 and protein synthesis. 90
Stress Granules formation and cell survival are reduced in Fmr1 knockout astrocytes after exposure to oxidative stress 88
Stress granules formation and cell survival are differently modulated by group-I metabotropic glutamate receptor activation in wild type and fmr1 knockout astrocytes 87
Activation of group-I metabotropic glutamate receptors impairs stress granules formation and enhances cellular damage under stress condition. 84
Mitochondrial alterations in a mouse model of Fragile X syndrome 83
EEG Abnormalities as a Neurophysiological Biomarker of Severity in Autism Spectrum Disorder: A Pilot Cohort Study 79
Dynamics of astrocytes Ca2+ signaling: a low-cost fluorescence customized system for 2D cultures 75
Role of fragile X messenger ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective 75
Reversal of mGluR-LTD by 5-HT7 receptor activation in the hippocampus of wild type and Fmr1 knockout mice 74
Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome 73
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism 70
Espressione della ossido nitrico sintasi neuronale (nNOS) in astrociti reattivi in vitro e in vivo. 66
Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice 65
ACTIVATION OF METABOTROPIC GLUTAMATE (mGLU) RECEPTOR SUBTYPE MGLU5 REDUCES THE INTERACTION BETWEEN FRAGILE X MENTAL RETARDATION PROTEIN (FMRP) AND THE FRAX RELATED PROTEINS FXR1P AND FXR2P. 64
Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid 62
A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome. 60
A PRETREATMENT WITH MPEP, A SPECIFIC METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 ANTAGONIST, PROTECTS AGAINST AMPA-MEDIATED MOTOR NEURON DEATH IN MIXED SPINAL CORD CULTURES. 59
Metabotropic Glutamate Subtype 5 (mGlu5) Receptor-Mediated Modulation of the Interaction between Fragile X Mental Retardation Protein (FMRP) and THE Fragile X Related (FXR) Proteins FXR1P and FXR2P 59
La 3° Missione all'interno di IRIB 58
Fragile X mental retardation protein (FMRP) and metabotropic glutamate receptor subtype 5 (mGlu5) control stress granule formation in astrocytes 56
A PRETREATMENT WITH MPEP, A SPECIFIC METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 ANTAGONIST, PROTECTS AGAINST AMPA-MEDIATED MOTOR NEURON DEATH IN MIXED SPINAL CORD CULTURES. 55
Differential patterns of Notch1-4 receptor expression are markers of glioma cell differentiation. 54
Viability of olfactory ensheathing cells after hypoxia and serum deprivation: implication for therapeutic transplantation 51
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome 51
Develeptomental effects of calcitonin gene-related peptide (CGRP) on cerebellar astrocytes and Purkinje cells 50
Effects of 5-HT7 receptor activation on dendritic spines and mGluR-LTD in Wild Type and Fmr1 knockout mice. 50
Presentazione Istituto IRIB 50
Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway. 47
Activation of group-I metabotropic glutamate receptor reduces stress granules formation through a mechanism mediated by FMRP. 47
5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission 45
Dysfunctions of metabotropic glutamate receptor subtype 5 (mGlu5) receptors in a mouse model of Fragile X syndrome 44
Human Low/High grade gliomas differentially induce PLA2 expression in brain microvascular endothelial cells. 44
The antineoplastic drug flavopiridol reverses memory impairmentinduced by Amyloid-ß1-42oligomers in mice 43
The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum 41
Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and fmr1 knockout mice, a model of fragile X syndrome 41
Endothelin-1: a new pharmacological target for Amyotrophic Lateral Sclerosis? 40
Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism 39
Altered expression of mGlu5 receptor and its regulatory proteins in several Autism Spectrum Disorders. 39
Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death. 38
Endothelin-1 induces degeneration of motor neurons: a possible pharmacological target for amyotrophic lateral sclerosis. 38
Notch receptors expression in glioma cell lines under different culture conditions. 37
5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders 35
Calcitonin Gene-Related Peptide (CGRP) stimulates Purkinje cell dendrite growth in culture. 35
Notch receptors as marker of glioma grading 34
Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development 34
FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. 33
Analysis of differential expression of Notch receptors in gliomas. 33
MARKERS OF STEM CELLS IN GLIOMAS 32
A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death 32
Endothelin-1 induces motor neuron degeneration in an in vitro model of ALS 32
Expression of pannexin1 in the CNS of adult mouse: cellular localization and effect of 4-aminopyridine-induced seizures. 32
Metabotropic Glutamate Receptors and Neuroplasticity 32
A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death. 31
Regulation of gene expression byb excitatory amino acids in cultured astrocytes 31
Stress granules formation and cell survival are differently modulated by group-I metabotropic glutamate receptor activation in wild type and fmr1 knockout astrocytes. 31
Neurobiologia dello sviluppo 31
Synapses as therapeutic targets for Autism Spectrum Disorders: an International Symposium held in Pavia on July 4th, 2014. 30
Fragile X Syndrome: From Pathophysiology to New Therapeutic Perspectives. 30
An increased expression of the mGlu5 receptor protein following LTP inductionat the perforant path-dentate gyrus synapse in freely moving rats. 30
Changes in mGlu5 Receptor-Dependent Synaptic Plasticity and Coupling to Homer Proteins in the Hippocampus of Ube3A Hemizygous Mice Modeling Angelman Syndrome 30
Differential patterns of Notch1-4 receptor expression are possible markers of glioma cell differentiation 29
Endothelin-1 induces degeneration of cultured motor neurons: underlying mechanisms 29
Effects of hypoxia and serum deprivation on survival of cultured olfactory ensheathing cells 29
Distribution of group I metabotropic glutamate receptors in the spinal cord in transgenic mice (G93A) 29
Involvement of GROUP-I metabotropic glutamate receptors in the pathophysiology of Fragile X syndrome 29
Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C-Neuroligin 3 Mouse Model of Autism Spectrum Disorder 29
The 3 UTR of FMR1 mRNA is a target of miR-101, miR-129-5p and miR-221: implications for the molecular pathology of FXTAS at the synapse 29
Effect of different growth factors on olfactory ensheathing cells exposed to hypoxia and/or serum deprivation: implication for therapeutic approaches. 29
Object recognition impairment in Fmr1 knock out mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. 28
INVOLVEMENT OF GROUP-I METABOTROPIC GLUTAMATE RECEPTORS IN THE PATHOPHYSIOLOGY OF FRAGILE X SYNDROME 28
Dysregulation of group-I metabotropic glutamate subtype 5 (mGlu5) receptors in a mouse model of Fragile X syndrome. 28
Altered surface dynamics of mGlu5 receptor in a mouse model of Fragile X Syndrome 28
Metabotropic glutamate receptors in glial cells. 28
Expression of FMRP interacting proteins in wild type and FMR1 knock-out mice brain during development 28
gamma-secretase inhibitor blocks Notch processing and induces apoptosis in glioma cell cultures 28
Differential expression of cyclooxygenase-1 and cyclooxygenase-2 in the cornea during wound healing. 27
In vitro and in vivo models of neurological disorders. 27
A chronic blockade of metabotropic glutamate receptor subtype 5 exerts a protective effect against motor neuron degeneration 27
DISTRIBUTION OF METABOTROPIC GLUTAMATE RECEPTORS IN THE SPINAL CORD OF TRANSGENIC MICE G93A 26
Role of metabotropic glutamate receptors in the pathophysiology of neurodevelopment and neurodegeneration. 26
Audiogenic Seizure Susceptibility is reduced in Fragile X Knockout Mice after Introduction 26
mGlu5 receptor expression and interaction with Homer proteins in a mouse model of FRAX syndrome 26
Region specific changes in the expression of metabotropic glutamate receptors of aging rat brains 26
Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells 26
A chronic treatment with MPEP, a specific metabotropic glutamate receptor subtype 5 antagonist, exerts a protective effect against motor neuron degeneration 26
Human Low/High grade gliomas differentially induce PLA2 expression in brain microvascular endothelial cells. 26
Surface dynamics of mGlu5 receptors in a mouse model of fragile X syndrome 26
A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model 25
Surface expression and distribution of mGlu5 receptors in hippocampal WT and FMR1 KO neurons. 25
Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by beta-amyloid peptide 1-42 25
Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. 25
Activation of metabotropic glutamate subtype 5 (mGlu5) receptors modulates the interaction between Fragile X (FRAX) mental retardation protein (FMRP) and the FRAX related proteins FXR1P and FXR2P 25
Immunohistochemical localization of group I and II metabotropic glutamate receptors in an animal model of Amyotrophic Lateral Sclerosis. 24
Developmental pattern of FMRP interacting proteins in the mouse brain 24
Regional reduction of m2 muscarinic receptors in a mouse model of FRAX syndrome 24
Reduction of AMPA GluR-D subunit and mGlu5 receptor in the triton-insoluble fraction of synaptic plasma membrane (SPMs) from Fmr1 knock out mice 24
Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by ?-amyloid peptide 1-42 24
A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome. 23
Role of glutamate metabotropic receptors (mGluRs) in spinal motor neuron degeneration 23
Totale 4.115
Categoria #
all - tutte 15.860
article - articoli 6.700
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 601
Totale 23.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 3 1 18 0
2024/20251.892 18 6 132 85 507 62 30 84 51 81 458 378
2025/20262.923 162 316 270 431 520 73 473 183 221 142 132 0
Totale 4.837